BKIDC-1553 is an orally active antiglycolytic agent and a bumped kinase inhibitor derived compound with a predicted ~17 h half-life in human. BKIDC-1553 inhibits CYP2C8 and Angiotensin Converting Enzyme and can be used for cancer research[1].
Molecular Weight:
389.45
Purity:
99.65
CAS Number:
[1951431-34-7]
Formula:
C22H23N5O2
Target:
Angiotensin-converting Enzyme (ACE)
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted